Baxter Healthcare News: Company Agrees To $18M Settlement For Sloppy Manufacturing Practices, Avoids Criminal Prosecution
January 13, 2017
Baxter Healthcare Corp. agreed to pay more than $18 million to avoid criminal prosecution and resolve civil penalties for failure to following proper manufacturing procedures in production of sterile drug products at its North Carolina plant, the Justice Department said Thursday.
The agreement includes $16 million in penalties and forfeiture, and $2.158 million in civil payments.